Gene Therapy for Rare Pediatric Brain Disease Shows Long-Term Benefit But Also Underscores Risks
October 18th 2024One of two new studies found most patients doing well six years after treatment. Another study found blood cancers in 17% of patients given the therapy using a slightly different protocol.
Read More
FDA Approves First RSV Vaccine for Pregnant Women to Protect Infants
August 24th 2023Monday’s action followed by one month the agency’s approval of another first — a monoclonal antibody immunization for newborns — against respiratory syncytial virus, the leading cause of infant hospitalizations in the United States
Read More
Insomnia Adds to the Economic Burden of All Five Comorbid Conditions Studied
July 14th 2023Between 9% and 12% of American adults have insomnia, and 85% of them also are diagnosed with comorbid conditions like type 2 diabetes and dementia. While the numerous health consequences of comorbid insomnia have been well-documented, the additional costs for specific disease groups have not been measured in large studies — until now.
Read More